30 April 2020

Safety Updates on Pharmaceutical Products & Alerts from Falsified Products

Reference: CIR-2020-00000156

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Falsified chloroquine products circulating in the WHO region of Africa
• Safety update of pharmaceutical products containing Cyproterone
• Safety update of pharmaceutical products containing Milnacipran Hydrochloride
• Safety Alert for medical device BD PCEA (Patient Controlled Epidural Analgesia) Administration sets
• Several falsified SARS–CoV-2 test kits sold online
• Provide controlled and narcotic drug products

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Falsified chloroquine products circulating in the WHO region of Africa.pdf:

View Document

Safety update of pharmaceutical products containing Cyproterone.pdf:

View Document

Safety update of pharmaceutical products containing Milnacipran Hydrochloride.pdf:

View Document

Safety Alert for medical device BD PCEA (Patient Controlled Epidural Analgesia) Administration sets.pdf:

View Document

Several falsified SARS–CoV-2 test kits sold online.pdf:

View Document

Provide controlled and narcotic drug products.pdf:

View Document